- Report
- March 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 388 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 279 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 311 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 189 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 279 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 177 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 188 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 194 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 197 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 180 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 379 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5084EUR$5,850USD£4,425GBP

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more